Page last updated: 2024-08-23

paroxetine and Cerebral Infarction

paroxetine has been researched along with Cerebral Infarction in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Poverennova, IE; Zolotovskaia, IA1
Higashiyama, S; Kawabe, J; Kiriike, N; Kohagura, K; Matsui, T; Matsunaga, H; Saxena, S1
Derex, L; Nighoghossian, N; Ostrowsky, K; Trouillas, P1
Erfurth, A1

Trials

1 trial(s) available for paroxetine and Cerebral Infarction

ArticleYear
[Clinical effects of paxil in poststroke rehabilitation].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2005, Volume: 105, Issue:1

    Topics: Adult; Aged; Brain; Carotid Artery, Internal; Cerebral Infarction; Cluster Analysis; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors

2005

Other Studies

3 other study(ies) available for paroxetine and Cerebral Infarction

ArticleYear
Secondary obsessive-compulsive disorder related to diaschisis after pontine infarction, successfully treated with paroxetine.
    Psychiatry and clinical neurosciences, 2007, Volume: 61, Issue:2

    Topics: Aged; Antidepressive Agents, Second-Generation; Cerebral Infarction; Cerebrovascular Circulation; Humans; Magnetic Resonance Imaging; Male; Obsessive-Compulsive Disorder; Paroxetine; Pons; Psychiatric Status Rating Scales; Temporal Lobe; Tomography, Emission-Computed, Single-Photon

2007
Severe pathological crying after left anterior choroidal artery infarct. Reversibility with paroxetine treatment.
    Stroke, 1997, Volume: 28, Issue:7

    Topics: Cerebral Arteries; Cerebral Infarction; Choroid Plexus; Crying; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors

1997
[Therapy of affect incontinence with paroxetine].
    Psychiatrische Praxis, 1997, Volume: 24, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Cerebral Infarction; Female; Humans; Middle Aged; Mood Disorders; Neurocognitive Disorders; Paroxetine

1997